Delivery of index-linked HIV testing for children: learnings from a qualitative process evaluation of the B-GAP study in Zimbabwe.
Barriers
Children
Facilitators
HIV
Implementation
Index-linked testing
Process evaluation
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
26 Apr 2023
26 Apr 2023
Historique:
received:
05
03
2022
accepted:
16
02
2023
medline:
28
4
2023
pubmed:
27
4
2023
entrez:
26
4
2023
Statut:
epublish
Résumé
Index-linked HIV testing for children, whereby HIV testing is offered to children of individuals living with HIV, has the potential to identify children living with undiagnosed HIV. The "Bridging the Gap in HIV Testing and Care for Children in Zimbabwe" (B-GAP) study implemented and evaluated the provision of index-linked HIV testing for children aged 2-18 years in Zimbabwe. We conducted a process evaluation to understand the considerations for programmatic delivery and scale-up of this strategy. We used implementation documentation to explore experiences of the field teams and project manager who delivered the index-linked testing program, and to describe barriers and facilitators to index-linked testing from their perspectives. Qualitative data were drawn from weekly logs maintained by the field teams, monthly project meeting minutes, the project coordinator's incident reports and WhatsApp group chats between the study team and the coordinator. Data from each of the sources was analysed thematically and synthesised to inform the scale-up of this intervention. Five main themes were identified related to the implementation of the intervention: (1) there was reduced clinic attendance of potentially eligible indexes due to community-based differentiated HIV care delivery and collection of HIV treatment by proxy individuals; (2) some indexes reported that they did not live in the same household as their children, reflecting the high levels of community mobility; (3) there were also thought to be some instances of 'soft refusal'; (4) further, delivery of HIV testing was limited by difficulties faced by indexes in attending health facilities with their children for clinic-based testing, stigma around community-based testing, and the lack of familiarity of indexes with caregiver provided oral HIV testing; (5) and finally, test kit stockouts and inadequate staffing also constrained delivery of index-linked HIV testing. There was attrition along the index-linked HIV testing cascade of children. While challenges remain at all levels of implementation, programmatic adaptations of index-linked HIV testing approaches to suit patterns of clinic attendance and household structures may strengthen implementation of this strategy. Our findings highlight the need to tailor index-linked HIV testing to subpopulations and contexts to maximise its effectiveness.
Sections du résumé
BACKGROUND
BACKGROUND
Index-linked HIV testing for children, whereby HIV testing is offered to children of individuals living with HIV, has the potential to identify children living with undiagnosed HIV. The "Bridging the Gap in HIV Testing and Care for Children in Zimbabwe" (B-GAP) study implemented and evaluated the provision of index-linked HIV testing for children aged 2-18 years in Zimbabwe. We conducted a process evaluation to understand the considerations for programmatic delivery and scale-up of this strategy.
METHODS
METHODS
We used implementation documentation to explore experiences of the field teams and project manager who delivered the index-linked testing program, and to describe barriers and facilitators to index-linked testing from their perspectives. Qualitative data were drawn from weekly logs maintained by the field teams, monthly project meeting minutes, the project coordinator's incident reports and WhatsApp group chats between the study team and the coordinator. Data from each of the sources was analysed thematically and synthesised to inform the scale-up of this intervention.
RESULTS
RESULTS
Five main themes were identified related to the implementation of the intervention: (1) there was reduced clinic attendance of potentially eligible indexes due to community-based differentiated HIV care delivery and collection of HIV treatment by proxy individuals; (2) some indexes reported that they did not live in the same household as their children, reflecting the high levels of community mobility; (3) there were also thought to be some instances of 'soft refusal'; (4) further, delivery of HIV testing was limited by difficulties faced by indexes in attending health facilities with their children for clinic-based testing, stigma around community-based testing, and the lack of familiarity of indexes with caregiver provided oral HIV testing; (5) and finally, test kit stockouts and inadequate staffing also constrained delivery of index-linked HIV testing.
CONCLUSIONS
CONCLUSIONS
There was attrition along the index-linked HIV testing cascade of children. While challenges remain at all levels of implementation, programmatic adaptations of index-linked HIV testing approaches to suit patterns of clinic attendance and household structures may strengthen implementation of this strategy. Our findings highlight the need to tailor index-linked HIV testing to subpopulations and contexts to maximise its effectiveness.
Identifiants
pubmed: 37101147
doi: 10.1186/s12879-023-08088-0
pii: 10.1186/s12879-023-08088-0
pmc: PMC10131435
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
262Subventions
Organisme : Wellcome Trust
ID : 220098/Z/20/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206316/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : Medical Research Council
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
Hum Resour Health. 2015 Sep 10;13:76
pubmed: 26358250
PLoS Med. 2017 Jul 25;14(7):e1002360
pubmed: 28742829
AIDS Care. 2010 Sep;22(9):1101-7
pubmed: 20824563
J Acquir Immune Defic Syndr. 2018 Aug 15;78 Suppl 2:S88-S97
pubmed: 29994830
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Curr Opin HIV AIDS. 2018 May;13(3):257-264
pubmed: 29401121
J Acquir Immune Defic Syndr. 2019 Dec 1;82(4):368-372
pubmed: 31425318
J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):393-399
pubmed: 29280769
Qual Health Res. 1999 Jan;9(1):26-44
pubmed: 10558357
BMJ Glob Health. 2016 Oct 24;1(3):e000004
pubmed: 28588949
AIDS. 2018 Sep 10;32(14):1977-1982
pubmed: 29927784
J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):e24-9
pubmed: 26473799
PLoS One. 2016 Jun 09;11(6):e0155510
pubmed: 27280282
BMJ Open. 2019 Jul 9;9(7):e029428
pubmed: 31289091
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):e83-e89
pubmed: 27846074
Trop Med Int Health. 2017 Aug;22(8):1021-1029
pubmed: 28544728
BMC Pediatr. 2018 Sep 25;18(1):309
pubmed: 30253758
BMC Health Serv Res. 2021 Oct 12;21(1):1082
pubmed: 34641871
BMJ. 2004 Nov 13;329(7475):1147-50
pubmed: 15539670
J Int AIDS Soc. 2012 Feb 22;15(1):8
pubmed: 22353553
AIDS Care. 2013;25(12):1520-6
pubmed: 23528004
Curr HIV/AIDS Rep. 2020 Oct;17(5):458-466
pubmed: 32844274
PLoS One. 2019 Mar 27;14(3):e0212762
pubmed: 30917167
Soc Sci Med. 2010 Jan;70(2):313-20
pubmed: 19853339
Lancet HIV. 2021 Mar;8(3):e138-e148
pubmed: 33197393
Implement Sci Commun. 2020 Nov 4;1(1):99
pubmed: 33292817
PLoS Med. 2014 May 27;11(5):e1001649
pubmed: 24866209
J Int AIDS Soc. 2015 Oct 14;18:20182
pubmed: 26471265
Lancet. 2018 Jul 28;392(10144):312-358
pubmed: 30032975